Skip to main content
Vcanbio Cell & Gene Engineering Corp., Ltd logo

Vcanbio Cell & Gene Engineering Corp., Ltd — Investor Relations & Filings

Ticker · 600645 ISIN · CNE000000545 LEI · 300300FLWFDJPQYVAZ24 Shanghai Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,580 across all filing types
Latest filing 2019-09-09 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600645

About Vcanbio Cell & Gene Engineering Corp., Ltd

https://www.vcanbio.com/

Vcanbio Cell & Gene Engineering Corp., Ltd. specializes in the fields of cell therapy, gene technology, and precision medicine. The company operates a comprehensive business model centered on the storage of hematopoietic and mesenchymal stem cells, providing long-term bio-banking services for cord blood and other biological tissues. Its technical portfolio includes advanced genetic testing services, such as prenatal screening and oncology diagnostics, alongside the development of cell-based therapeutic products. Vcanbio maintains a network of specialized laboratories and storage facilities to support clinical research and personalized healthcare applications. The organization focuses on translating biotechnological advancements into clinical solutions, emphasizing quality control in cell processing and genomic analysis to serve the evolving needs of the regenerative medicine and diagnostic sectors.

Recent filings

Filing Released Lang Actions
关于控股股东部分股权质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the controlling shareholder of the company. It details the number of shares pledged, the percentage of total shares, the purpose of the pledge, and risk mitigation measures. There is no financial data, no mention of financial results, no regulatory certifications, or meeting materials. The document is a disclosure about a capital-related event (share pledge) by a major shareholder, which fits best under Capital/Financing Update (CAP). The document length is short and it is not an announcement of a report publication, so it is not RPA. Therefore, the classification is CAP with high confidence.
2019-09-09 Chinese
2019年第四次临时股东大会会议资料
AGM Information Classification · 100% confidence The document is titled as materials for the "2019 Fourth Extraordinary General Meeting of Shareholders" of Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. It includes detailed meeting agenda, voting procedures, and multiple proposals for amendments to the company's articles of association, shareholder meeting rules, board meeting rules, and independent director work system. The content is focused on the meeting materials and agenda for a specific shareholders' meeting, not the results of voting or a report of the meeting itself. It is not a full annual or interim report, nor an earnings release or audit report. It is not a proxy solicitation or voting results announcement. The document is a presentation of materials shared for the shareholders' meeting, which fits the definition of AGM Information (AGM-R). The document length is over 10,000 characters, indicating it is the actual meeting materials, not just an announcement of a report publication. Therefore, the correct classification is AGM Information (AGM-R).
2019-09-06 Chinese
关于控股股东部分股权解除质押及再质押的公告
Capital/Financing Update Classification · 95% confidence The document is a public announcement by Zhongyuan Xiehe Cell Gene Engineering Co., Ltd. regarding the release and re-pledging of shares by its controlling shareholder. It details the number of shares released from pledge, new shares pledged, cumulative pledged shares, and the purpose and risks associated with the pledge. The content focuses on share pledge and financing activities by a major shareholder, which is typical of capital or financing updates. The document is short (1179 characters) and does not contain financial statements or detailed financial performance data, so it is not an Annual Report or Interim Report. It is not a voting result, management change, or legal proceeding. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2019-09-05 Chinese
公司章程（修订稿）
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association (章程) for 中源协和细胞基因工程股份有限公司. It includes comprehensive provisions on company organization, shareholder rights, board of directors, shareholder meetings, share issuance, and other governance matters. It references laws such as the Company Law and Securities Law of China, and details the rights and obligations of shareholders, procedures for shareholder meetings, and board responsibilities. This type of document is a governance document that sets internal rules and structure for the company rather than a financial report, announcement, or meeting material. It is not an Annual Report, Interim Report, Earnings Release, nor a voting result announcement. It is not a proxy statement or remuneration report. It is a governance document outlining the company's internal rules and governance practices. Therefore, the appropriate classification is Governance Information (CGR). The document length is substantial and contains the full text of the governance rules, not just an announcement or summary, so it is not RPA or RNS.
2019-08-29 Chinese
总经理（总裁）工作细则
Board/Management Information Classification · 95% confidence The document is a detailed internal regulation titled 'General Manager (President) Work Rules' for a company, outlining the duties, responsibilities, appointment, and conduct of the general manager and other senior management personnel. It references company law, governance codes, and company bylaws but does not contain financial data, audit information, or any report on financial performance. It is not an announcement or a report of financial results, nor is it related to shareholder meetings or voting. The content is focused on management roles and governance practices related to senior executives. Therefore, the document fits best under 'Board/Management Information (MANG)' as it pertains to management rules and structure rather than financial reporting or other categories.
2019-08-29 Chinese
关于变更注册资本及修订公司章程的公告
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from a company regarding changes in its registered capital and amendments to its articles of association (company bylaws). It details the issuance of new shares, approval from the securities regulatory commission, and specific revisions to the company's charter. The document is not a full financial report but rather a formal announcement of corporate governance changes and capital structure updates. It does not contain financial statements or detailed financial analysis. The document length is 3406 characters, which is relatively short and consistent with an announcement rather than a full report. The content fits best with a Share Issue/Capital Change announcement, as it focuses on the increase in registered capital due to share issuance and related amendments to the company charter. Therefore, the appropriate classification is Share Issue/Capital Change (SHA).
2019-08-29 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.